Llwytho...
Synthetic lethality in lung cancer and translation to clinical therapies
Lung cancer is a heterogeneous disease consisting of multiple histological subtypes each driven by unique genetic alterations. Despite the development of targeted therapies that inhibit the oncogenic mutations driving a subset of lung cancer cases, there is a paucity of effective treatments for the...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mol Cancer |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5041331/ https://ncbi.nlm.nih.gov/pubmed/27686855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-016-0546-y |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|